Employing innovative solutions to accelerate drug discovery and development
Zenovel is dedicated to enhancing drug development and discovery by offering advanced solutions, addressing challenges, and bringing therapeutic ideas to fruition.
Drug research and discovery is an intricate field that involves knowledge, creativity, and accuracy. From original research to clinical development, Zenovel offers comprehensive services for every stage of the drug development process. Our comprehensive strategy guarantees that your medication/ drug candidates satisfy the highest requirements for efficacy, safety, and quality, and are optimised for success. We provide advanced drug development and discovery services, utilizing advanced technologies and a team of experienced scientists, to expedite the development of drug candidates, providing insights and support for innovative therapies.
Zenovel’s Chemistry Services provide comprehensive support in medicinal and synthetic
chemistry, enabling the development of innovative therapeutics from concept to clinic, leveraging the expertise and resources required for drug discovery and development.
Our team, comprising experts in chemistry, biology, pharmacology, and regulatory affairs, offers comprehensive support for drug development projects.
We utilize the latest technologies and methodologies to enhance innovation and efficiency in drug discovery and development.
Works closely with clients to create conducive environment that enhances project success and expedites development timelines.
We guarantee the highest quality and regulatory compliance, ensuring your products meet all safety and efficacy guidelines.
We offer tailored services to meet the unique needs of your projects, ensuring that your drug candidates are optimized for success.

India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles

The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although

Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play

In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to

Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,

Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.